Suppr超能文献

HIV-1 亚型 B 整合酶中 M50I 和 V151I 多态性突变的组合导致自身加工缺陷。

A Combination of M50I and V151I Polymorphic Mutations in HIV-1 Subtype B Integrase Results in Defects in Autoprocessing.

机构信息

Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD 21702, USA.

Virus Isolation and Serology Laboratory, Frederick National Laboratory, Frederick, MD 21702, USA.

出版信息

Viruses. 2021 Nov 22;13(11):2331. doi: 10.3390/v13112331.

Abstract

We have recently reported that a recombinant HIV-1NL4.3 containing Met-to-Ile change at codon 50 of integrase (IN) (IN:M50I) exhibits suppression of the virus release below 0.5% of WT HIV, and the released viral particles are replication-incompetent due to defects in Gag/GagPol processing by inhibition of the initiation of autoprocessing of GagPol polyproteins in the virions and leads to replication-incompetent viruses. The coexisting Ser-to-Asn change at codon 17 of IN or Asn-to-Ser mutation at codon 79 of RNaseH (RH) compensated the defective IN:M50I phenotype, suggesting that both IN and RH regulate an HIV infectability. In the current study, to elucidate a distribution of the three mutations during anti-retroviral therapy among patients, we performed a population analysis using 529 plasma virus RNA sequences obtained through the MiSeq. The result demonstrated that 14 plasma HIVs contained IN:M50I without the compensatory mutations. Comparing the sequences of the 14 viruses with that of the defective virus illustrated that only Val-to-Ile change at codon 151 of IN (IN:V151I) existed in the recombinant virus. This IN:V151I is known as a polymorphic mutation and was derived from HIVNL4.3 backbone. A back-mutation at 151 from Ile-to-Val in the defective virus recovered HIV replication capability, and Western Blotting assay displayed that the back-mutation restored Gag/GagPol processing in viral particles. These results demonstrate that a combination of IN:M50I and IN:V151I mutations, but not IN:M50I alone, produces a defective virus.

摘要

我们最近报道了一种含有整合酶(IN)第 50 位密码子由蛋氨酸突变为异亮氨酸(IN:M50I)的重组 HIV-1NL4.3,其病毒释放被抑制在 WT HIV 的 0.5%以下,且由于 Gag/GagPol 加工过程中存在缺陷,释放的病毒颗粒无复制能力,这是由于抑制了病毒粒子中 GagPol 多蛋白的自我切割起始,从而导致复制缺陷型病毒。IN 的第 17 位密码子丝氨酸突变为天冬酰胺或 RNaseH(RH)的第 79 位天冬酰胺突变为丝氨酸的共存变化补偿了缺陷型 IN:M50I 表型,表明 IN 和 RH 都调节 HIV 的感染性。在本研究中,为了阐明在接受抗逆转录病毒治疗的患者中三种突变的分布情况,我们使用通过 MiSeq 获得的 529 个血浆病毒 RNA 序列进行了群体分析。结果表明,14 个血浆 HIV 中含有没有补偿性突变的 IN:M50I。将这 14 种病毒的序列与缺陷病毒的序列进行比较,结果表明只有 IN 的第 151 位密码子由缬氨酸突变为异亮氨酸(IN:V151I)。这种 IN:V151I 是一种多态性突变,源自 HIVNL4.3 骨架。在缺陷病毒中,151 位由异亮氨酸回突变为缬氨酸,恢复了 HIV 复制能力,Western Blotting 检测显示回突变回恢复了病毒颗粒中 Gag/GagPol 的加工。这些结果表明,只有 IN:M50I 和 IN:V151I 突变的组合,而不是单独的 IN:M50I,会产生缺陷型病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535a/8625782/67faf68765c9/viruses-13-02331-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验